Cathepsin L Inhibitor I, with the CAS number 105608-85-3, is a small molecule that functions as a selective inhibitor of the cathepsin L enzyme, which is a cysteine protease involved in various physiological and pathological processes, including protein degradation and immune response. This compound is characterized by its ability to modulate cathepsin L activity, making it a valuable tool in research related to cancer, inflammation, and other diseases where cathepsin L plays a critical role. The inhibitor is typically studied for its potential therapeutic applications, particularly in conditions where excessive proteolytic activity contributes to disease progression. In terms of its chemical properties, it may exhibit specific solubility characteristics, stability under various conditions, and a defined mechanism of action that involves binding to the active site of cathepsin L. Overall, Cathepsin L Inhibitor I serves as an important compound in biochemical research and drug development, particularly in the context of targeting proteolytic enzymes.

CATHEPSIN L INHIBITOR I

105608-85-3: Cathepsin L Inhibitor I, with the CAS number 105608-85-3, is a small molecule that functions as a selective inhibitor of the cathepsin L enzyme, which is a cysteine protease involved in various physiological and pathological processes, including protein degradation and immune response. This compound is characterized by its ability to modulate cathepsin L activity, making it a valuable tool in research related to cancer, inflammation, and other diseases where cathepsin L plays a critical role. The inhibitor is typically studied for its potential therapeutic applications, particularly in conditions where excessive proteolytic activity contributes to disease progression. In terms of its chemical properties, it may exhibit specific solubility characteristics, stability under various conditions, and a defined mechanism of action that involves binding to the active site of cathepsin L. Overall, Cathepsin L Inhibitor I serves as an important compound in biochemical research and drug development, particularly in the context of targeting proteolytic enzymes.

Carbamic acid, N-[(1S)-2-[[(1S)-3-fluoro-2-oxo-1-(phenylmethyl)propyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-, phenylmethyl ester

CAS 105608-85-3

CATHEPSIN L INHIBITOR I

Carbamic acid, N-[(1S)-2-[[(1S)-3-fluoro-2-oxo-1-(phenylmethyl)propyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-, phenylmethyl ester

Ref: 54-PC1006504